Aardvark Therapeutics Inc...

8.27
-0.25 (-2.93%)
At close: Apr 24, 2025, 3:59 PM
7.80
-5.68%
Pre-market: Apr 25, 2025, 05:18 AM EDT

Aardvark Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2024 Q3 2024 Q4 2023 Q3 2023
Period Ending Dec 31, 2024 Sep 30, 2024 Dec 31, 2023 Sep 30, 2023
-8.78M -4.18M -2.04M -2.11M
-121K 87K 25K 26K
173K 145K 69K 72K
-378K 488K -238K -260K
185K 91K 97K 742K
n/a n/a n/a n/a
815K -96K 694K -316K
-7.73M -3.96M -1.16M -1.58M
-6K -5K n/a n/a
n/a n/a n/a n/a
n/a n/a n/a n/a
n/a n/a n/a n/a
-11.89M n/a n/a n/a
-11.89M -5K n/a n/a
n/a n/a n/a n/a
n/a n/a n/a n/a
n/a n/a n/a n/a
-1.18M 64K n/a n/a
-1.01M 64K n/a n/a
-20.64M -3.9M -1.16M -1.58M
-7.73M -3.96M -1.16M -1.58M